AI assistant
Sending…
KIORA PHARMACEUTICALS INC — Director's Dealing 2021
Nov 10, 2021
35256_dirs_2021-11-10_f6d77713-4d09-499b-8157-5c86b4f78980.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: KIORA PHARMACEUTICALS INC (KPRX)
CIK: 0001372514
Period of Report: 2021-10-21
Reporting Person: Daniels Eric Joseph (Chief Development Officer)
More from KIORA PHARMACEUTICALS INC
Share Issue/Capital Change
2026
May 28
Regulatory Filings
2026
May 18
Earnings Release
2026
May 8
Interim / Quarterly Report
2026
May 8
Annual Report
2026
May 1
Capital/Financing Update
2026
Apr 7
Board/Management Information
2026
Apr 2
Capital/Financing Update
2026
Mar 25
Earnings Release
2026
Mar 25
Annual Report
2026
Mar 25